AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2017

Nov 17, 2017

30071_dirs_2017-11-17_a31adfbd-760b-4bda-9d16-e7d47be4f3bd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-11-16

Reporting Person: FARRELL PETER C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-16	ResMed Common Stock	A	2991	$84.98	Acquired	295933	Direct

Footnotes

F1: Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2018, or the annual shareholder's meeting in the year following the grant date.